1150617-80-3

Basic information

• Product Name: 5-Bromo-3-methoxy-2-methylpyridine
• Synonyms: 5-Bromo-3-methoxy-2-methylpyridine
• CAS NO: 1150617-80-3
• Molecular Formula: C7H8BrNO
• Molecular Weight: 202.04852
• Mol File: 1150617-80-3.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 219℃
• Flash Point: 86℃
• Appearance: /
• Density: 1.452
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: 3.67±0.10(Predicted)
• CAS DataBase Reference: 5-Bromo-3-methoxy-2-methylpyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-3-methoxy-2-methylpyridine(1150617-80-3)
• EPA Substance Registry System: 5-Bromo-3-methoxy-2-methylpyridine(1150617-80-3)

Safety Data

• Hazardous Substances Data: 1150617-80-3(Hazardous Substances Data)

Usage

General Description

5-Bromo-3-methoxy-2-methylpyridine is a chemical compound with the molecular formula C7H8BrNO. It is a pyridine derivative that contains a bromine atom, a methoxy group, and a methyl group attached to the pyridine ring. 5-Bromo-3-methoxy-2-methylpyridine is commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. Its unique structure and functional groups make it a valuable intermediate in the production of various compounds with diverse biological and chemical properties. 5-Bromo-3-methoxy-2-methylpyridine is also a useful reagent in the field of organic chemistry, serving as a substrate for the preparation of new molecules and materials.

Upstream product

• 91420-25-6 2-methyl-3-hydroxy-5-bromopyridine 
• 74-88-4 methyl iodide 
• 914358-73-9 5-bromo-2-methylpyridin-3-ylamine 
• 1142191-57-8 2,5-dibromo-3-methoxy-pyridine 
• 75-16-1 methylmagnesium bromide 

Relevant articles and documents

C3-SUBSTITUTED 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS

Compounds according to formula I are useful as agonists of Toll-like receptor 7 (TLR7). Such compounds can be used in cancer treatment, especially in combination with an anti-cancer immunotherapy agent, or as a vaccine adjuvant.

Catalytic Enantioselective Synthesis of Pyridyl Sulfoximines

With unique chemical and biological activity, sulfoximines have attracted enormous attention in the past decades, whereas limited reports exist for their synthesis via asymmetric catalysis. We report the synthesis of chiral sulfoximines through the desymmetrizing N-oxidation of pyridyl sulfoximines using an aspartic acid-containing peptide catalyst. Various mono- and bis-pyridyl sulfoximine oxides are obtained with up to 99:1 er. The directing group introduced on the substrate highly enhances the enantioinduction and could be easily removed to give the free N-H sulfoximines. Additionally, peptides with methyl ester and the methyl amide C-terminal protecting group give the opposite enantiomers of the product. A binding model is proposed to explain this phenomenon.

TRI-CYCLIC PYRAZOLOPYRIDINE KINASE INHIBITORS

The present invention relates to compounds useful as inhibitors of P13K, particularly of P13Kgamma. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of several diseases, such as cancer and autoimmune diseases.